Zeleznik, Oana A.
Kang, Jae H. http://orcid.org/0000-0003-4812-0557
Lasky-Su, Jessica http://orcid.org/0000-0001-6236-4705
Eliassen, A. Heather http://orcid.org/0000-0002-3961-6609
Frueh, Lisa
Clish, Clary B. http://orcid.org/0000-0001-8259-9245
Rosner, Bernard A. http://orcid.org/0000-0001-6907-0056
Elze, Tobias http://orcid.org/0000-0002-2032-0496
Hysi, Pirro http://orcid.org/0000-0001-5752-2510
Khawaja, Anthony http://orcid.org/0000-0001-6802-8585
Wiggs, Janey L. http://orcid.org/0000-0003-1890-3278
Pasquale, Louis R.
,
Article History
Received: 16 July 2022
Accepted: 4 May 2023
First Online: 19 May 2023
Competing interests
: L.R.P. is a consultant to Eyenovia, Twenty Twenty, Character Bio, and Skye Biosciences. J.L.W. is a consultant to Allergan, Avellino, Editas, Maze, Regenxbio and has received research support from Aerpio Pharmaceuticals. A.K. is a consultant to Abbvie, Aerie, Google Health, Novartis, Reichert, Santen, and Thea. J.H.K. has received research support from Pfizer, Inc. The remaining authors declare no other competing interests.